Market Scenario
The Asia Pacific Blood Glucose Test Strip Market Size is expected to reach USD 3415.49 Million by 2030 at 5.80% CAGR during the forecast period 2022-2030.
Blood glucose test strip are small disposable and they are used to monitor the blood glucose level. It plays an important role in the blood glucose monitoring and treatment of diabetes. Total diabetic population in China is 113 million, which accounts 11% of total Chinese population, whereas 67 million people in India have diabetes. Additionally, 20% of population from most of the South Indian cities have diabetes. According to a study, China has the highest smoking rate and smoking increases the chances of developing diabetes by 45% as compare to non-smoker, which, in turn, will drive the growth of the APAC Blood Glucose Test Strip Market over the assessment period.
Asia Pacific Blood Glucose Test Strip Market Overview and Research Report Information: By Types (Glucose Oxidase, Glucose Dehydrogenase, other), Technology (Wicking Technology and Channel Technology), and End User (Hospital, Clinic, Household) -Forecast till 2030
Key Players:
Some of the major Asia Pacific Blood Glucose Test Strip Market Players are F. Hoffmann-La Roche Ltd (Switzerland), Abbott (US), LifeScan, Inc. (US), i-SENS. Inc. (South Korea), AgaMatrix (US), TaiDoc Technology Corporation (Taiwan), BioSensors, Inc. (US), Universal Biosensors (Australia), Beijing Yicheng Electronic Co., Ltd (China), Hmd Biomedical (Taiwan), and B. Braun Melsungen Ag (Germany).
Segmentation
Asia Pacific Blood Glucose Test Strip Market is segmented on basis of types, technology and end users.
- On the basis of types, the market is segmented into glucose oxidase, glucose dehydrogenase, and other.
- On the basis of technology, the market is segmented into wicking technology and channel technology.
- On the basis of end user, the market is categorised in hospital, clinic, homecare, and others
Regional Analysis
Asia Pacific Blood Glucose Test Strip Market region is segmented into Japan, China, India, Australia, Republic of Korea, and Rest of Asia Pacific. India and China are two most populated countries in this region, which together accounts for 180 million of diabetic patient. Increasing diabetic population in these countries has attracted many of the multinational companies to enter in the market. Overweight and obesity are majorly responsible for developing diabetes. Additionally, poor diet plan and lack of exercise contribute to the increasing diabetic population and India and China have the huge obese and overweight population. Thus, increasing prevalence of diabetes, obesity, increasing demand for the homecare devices, and increasing healthcare expenditure drive the market growth. Moreover, increasing per capita income and increasing awareness will push the market growth over the forecasted period.
Buy Now- https://www.marketresearchfuture.com/checkout?currency=one_user-USDreport_id=625
Related Report-
Keratoconus Treatment Market Research Report Forecast till 2027
Ayurvedic Products Market Research Report- Forecast to 2027
About US:
Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
